NCT05054153

Brief Summary

This is a dietary intervention study, which aims to explore different diet challenges for glucose metabolism, including carbohydrates and intermittent fasting (IF) dietary pattern. Considering the glucose responses to the same food are largely heterogeneous among people, this study integrates the concepts of precision nutrition and N-of-1 design. The study also aims to explore differences in brain structure and function between participants with different Body Mass Index (BMI) from the perspective of gut-brain axis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
176

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 23, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

October 8, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 27, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2022

Completed
Last Updated

September 5, 2023

Status Verified

August 1, 2021

Enrollment Period

3 months

First QC Date

August 24, 2021

Last Update Submit

August 31, 2023

Conditions

Keywords

Glucose MetabolismIntermittent fastingPersonalized NutritionBrainGut Microbiome

Outcome Measures

Primary Outcomes (2)

  • Blood glucose profiling

    Real-time blood glucose fluctuations will be recorded by CGM.

    14 days

  • Change of glucose tolerance before and after intermittent fasting

    Oral glucose tolerance test will also be conducted.

    Day 8 and Day 13

Other Outcomes (14)

  • Changes of fecal and urine metabolomics profiling

    Day 1, Day 8 , Day 11 and Day 14

  • Changes of serum metabolomics profiling

    Day 1, and Day 14

  • Changes of interleukin-1β (IL-1β), IL-6, IL-12

    Day 1, and Day 14

  • +11 more other outcomes

Study Arms (3)

refined carbohydrate breakfast (Breakfast A)

EXPERIMENTAL

white bread (50g) + milk powder (25g)

Other: refined carbohydrate breakfast

whole grain breakfast (Breakfast B)

EXPERIMENTAL

plain oats (35g) + milk powder (25g)

Other: whole grain breakfast

intermittent fasting (IF)

EXPERIMENTAL
Other: intermittent fasting

Interventions

After wearing CGM on Day 1, participants will be provided with breakfast A once daily on Day 2, Day 5 and Day 6. Breakfast A contains white bread (50g) and milk powder (25g). Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.

Also known as: Breakfast A
refined carbohydrate breakfast (Breakfast A)

After wearing CGM on Day 1, participants will be provided with Breakfast B once daily on Day 3, Day 4 and Day 7. Breakfast B contains plain oats (35g) and milk powder (25g). Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.

Also known as: Breakfast B
whole grain breakfast (Breakfast B)

The period during Day 8 to Day 13 is intermittent fasting period. Participants will experience the moderate fasting on Day 9 and Day 12, which means their daily energy intake is expected to be controlled within 500-600 kcal limit. In these two days, participants will be provided with all three meals. Percentages of macronutrients of provided meals will follow the Recommended Dietary Health guidelines for Chinese residents. The oral glucose tolerance test (OGTT) will be conducted in the morning on Day 8 and Day 13, to test short-term impact of IF intervention on individuals' glucose tolerance. The breakfasts on Day 10 and Day 11 will be the same as that in fasting days. Other meals will be wash-out meals.

Also known as: IF
intermittent fasting (IF)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participants reside in Hangzhou
  • Participants have no traveling plans within 3 months

You may not qualify if:

  • Refusing or unable to give informed consent
  • Participants with chronic gastrointestinal diseases and take daily relevant medications
  • Participants with metabolic diseases including diabetes, hypertension and cardiovascular diseases (CVD)
  • Participants with craniocerebral trauma, cancer, liver disease, kidney disease, or other critical illness, or history of operation or medication
  • Participants with bulimia nervosa, post-traumatic stress disorder (PTSD), chronic anxiety and depression or other critical neuronal disorder or history of relevant medication
  • Being or to be pregnant or lactating.
  • Participants with history of alcohol or drug addiction, or smoke above 15 cigarettes per day
  • Concurrently participating other clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Westlake University

Hangzhou, Zhejiang, 310024, China

Location

Related Publications (1)

  • Zhang K, Fu Y, Gou W, Miao Z, Tian Y, Liang Y, Liang X, Shuai M, Xiao C, Wang J, Xu F, Jiang Z, Gao C, Ma S, Ordovas JM, Zheng JS. Quantification of personalized glycemic sensitivity to food and its potential for precision nutrition in a series of n-of-1 trials. Am J Clin Nutr. 2025 Aug;122(2):502-512. doi: 10.1016/j.ajcnut.2025.04.015. Epub 2025 Jun 19.

MeSH Terms

Conditions

OverweightObesityIntermittent Fasting

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsFastingFeeding BehaviorBehavior

Study Officials

  • Ju-Sheng Zheng, PhD

    Westlake University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2021

First Posted

September 23, 2021

Study Start

October 8, 2021

Primary Completion

December 27, 2021

Study Completion

July 12, 2022

Last Updated

September 5, 2023

Record last verified: 2021-08

Locations